Siemeister, Gerhard <br/><br/>
Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors   [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  02 2019 
 - 1404-1414 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-18-0628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Ataxia Telangiectasia Mutated Proteins--antagonists & inhibitors<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>HeLa Cells<br/>Humans<br/>Mice<br/>Neoplasms--drug therapy<br/>Phthalazines--pharmacology<br/>Piperazines--pharmacology<br/>Poly(ADP-ribose) Polymerase Inhibitors--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Taxoids--pharmacology<br/>Xenograft Model Antitumor Assays